GlassScriptPhysician profile
Timothy S Beck
NPI 1548223779
$1,061.74
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.62 · 2020: $61.36 · 2021: $371 · 2022: $300 · 2023: $218 · 2024: $58.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $496.59 | 2021-2024 | Vraylar |
| Lilly USA, LLC | $161.81 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.47 | 2019-2022 | |
| Daiichi Sankyo INC. | $41.46 | 2020-2021 | |
| Mylan Specialty L.P. | $35.90 | 2022 | |
| Exact Sciences Corporation | $35.09 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $34.07 | 2023 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $29.99 | 2020-2022 | |
| Pfizer INC. | $26.64 | 2019-2020 | |
| Abbott Laboratories | $20.76 | 2023 | Freestyle Libre 3 |
| Lundbeck LLC | $17.63 | 2023 | Rexulti |
| Linus Health, INC. | $17.46 | 2023 | |
| Glaxosmithkline, LLC. | $16.63 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.40 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.